Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Bradley Theodore Hyman, M.D., Ph.D.

Co-Author

This page shows the publications co-authored by Bradley Hyman and Rachel Bennett.
Connection Strength

5.561
  1. Tau reduction in aged mice does not impact Microangiopathy. Acta Neuropathol Commun. 2020 08 18; 8(1):137.
    View in: PubMed
    Score: 0.890
  2. Partial reduction of microglia does not affect tau pathology in aged mice. J Neuroinflammation. 2018 Nov 09; 15(1):311.
    View in: PubMed
    Score: 0.787
  3. Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease. Proc Natl Acad Sci U S A. 2018 02 06; 115(6):E1289-E1298.
    View in: PubMed
    Score: 0.745
  4. Enhanced Tau Aggregation in the Presence of Amyloid ß. Am J Pathol. 2017 Jul; 187(7):1601-1612.
    View in: PubMed
    Score: 0.709
  5. APOE4 derived from astrocytes leads to blood-brain barrier impairment. Brain. 2021 Dec 27.
    View in: PubMed
    Score: 0.244
  6. Persistent repression of tau in the brain using engineered zinc finger protein transcription factors. Sci Adv. 2021 Mar; 7(12).
    View in: PubMed
    Score: 0.232
  7. Synaptic and metabolic gene expression alterations in neurons that are recipients of proteopathic tau seeds. Acta Neuropathol Commun. 2020 10 19; 8(1):168.
    View in: PubMed
    Score: 0.225
  8. Cerebrovascular Senescence Is Associated With Tau Pathology in Alzheimer's Disease. Front Neurol. 2020; 11:575953.
    View in: PubMed
    Score: 0.224
  9. Experimental evidence for the age dependence of tau protein spread in the brain. Sci Adv. 2019 06; 5(6):eaaw6404.
    View in: PubMed
    Score: 0.205
  10. Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease. Neuron. 2019 Jan 16; 101(2):349.
    View in: PubMed
    Score: 0.199
  11. Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease. Neuron. 2018 09 05; 99(5):925-940.e7.
    View in: PubMed
    Score: 0.194
  12. Tau reduction in the presence of amyloid-ß prevents tau pathology and neuronal death in vivo. Brain. 2018 07 01; 141(7):2194-2212.
    View in: PubMed
    Score: 0.192
  13. Tau protein liquid-liquid phase separation can initiate tau aggregation. EMBO J. 2018 04 03; 37(7).
    View in: PubMed
    Score: 0.187
  14. Studying tau protein propagation and pathology in the mouse brain using adeno-associated viruses. Methods Cell Biol. 2017; 141:307-322.
    View in: PubMed
    Score: 0.180
  15. Characterization of TauC3 antibody and demonstration of its potential to block tau propagation. PLoS One. 2017; 12(5):e0177914.
    View in: PubMed
    Score: 0.178
  16. Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons. J Neurosci. 2021 05 12; 41(19):4335-4348.
    View in: PubMed
    Score: 0.058
  17. Heterogeneity of Tau Deposition and Microvascular Involvement in MCI and AD. Curr Alzheimer Res. 2021; 18(9):711-720.
    View in: PubMed
    Score: 0.057
  18. PTEN activation contributes to neuronal and synaptic engulfment by microglia in tauopathy. Acta Neuropathol. 2020 07; 140(1):7-24.
    View in: PubMed
    Score: 0.054
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.